NATCO Pharma (India) acquisition of a stake in Adcock Ingram Holdings
- Value
- R4bn
- Date
- 10 October 2026
- Transaction type
- Acquisition
- Practice area
- Mergers and Acquisitions
- Sector
- Healthcare and Pharmaceuticals
- Jurisdiction
- South Africa
- Client
- NATCO Pharma (India)
Summary
NATCO Pharma (India) acquisition of a stake in Adcock Ingram Holdings. Value as disclosed: 4,000,000,000 ZAR.
Valued at ZAR 4bn per Bowmans profile. Described as a US$211m take-private of Adcock Ingram; Ezra Davids (Bowmans) named among the advisers (DealMakers SA 2025 Annual).
Why it matters
Major (USD 100m-1bn or award-winning)
Scope of legal work
Bowmans
Advisers
Other parties
NATCO Pharma (India) (acquirer or client); Adcock Ingram Holdings shareholders (counterparty or seller)
Other advisers
(advisers per Bowmans partner profile; deal date not stated)
Sources
Compiled by Meridian from the public announcements and filings listed under Sources.
Spotted an error? Suggest a correction.
Related
Related reporting
Intelligence
Kenya’s National Payment System Bill 2026 proposes ten licence categories and higher capital
Bowmans analysed Kenya's National Payment System Bill 2026, which would replace the 2014 framework.
Intelligence
The London corridor: African firms are hiring English-law capacity instead of renting it
Olaniwun Ajayi recruited a former HSF Kramer Johannesburg office managing partner into its London office in July 2026. Read against three other moves, it describes a…
Intelligence
Brands, broadcast rights and code: what 99 IP-linked deals reveal about Africa’s IP market
Meridian tracked 99 IP-linked transactions across Africa from October 2024 to October 2026. Brand licences, content rights and software now set prices in African M&A.